Izadi Neda, Koohi Fatemeh, Safarpour Mahdi, Naseri Parisa, Rahimi Salar, Khodakarim Soheila
Student Research Committee, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2020 Spring;13(2):125-132.
This study aimed to estimate the cure proportion and effects of related factors on colorectal cancer in Iranian patients after surgery.
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer death. The relative survival of CRC varies worldwide given the quality of care, including surgical techniques.
This retrospective cohort study was conducted on 490 patients, aged 20-94 years, with colorectal cancer. All the colorectal cancer patients undergoing surgery in Faghihi hospital, Shiraz University of Medical Sciences were prospectively followed-up for 8 years from 2008 to March 8, 2016. We used parametric cure model (mixture and non-mixture) to estimate the cure proportion and the adjusted hazard ration (HR) for colorectal cancer mortality after surgery. Data were analyzed by the "flexsurvcure" package in R software (version 3.4.2).
The median age of patients was 57.5 (interquartile range =18) years. Specifically, 56.33% of the patients were male. The median time of follow-up in patients was 618 days. The cumulative survival proportion varied from 0.90 to 0.49 which indicated a reduction followed by a flat line in the probability of survival by sex. The flexible survival for adjusted cure proportion (%) was 68.3. Only obesity was associated with a decreased risk of mortality (HR=0.34; 95% CI: 0.12-0.97).
The overall eight-year survival proportion and adjusted cure proportion for CRC were 49% and 68.3%, respectively. Knowing the cure proportion and its related factors in patients with CRC, better services can be provided. Thus, early detection and screening strategies are required to reduce mortality and increase survival of patients.
本研究旨在评估伊朗患者结直肠癌术后的治愈比例及相关因素的影响。
结直肠癌(CRC)是第三大常见诊断癌症,也是癌症死亡的第四大主要原因。鉴于包括手术技术在内的医疗质量,CRC的相对生存率在全球范围内有所不同。
本回顾性队列研究对490例年龄在20 - 94岁的结直肠癌患者进行。设拉子医科大学法吉希医院所有接受手术的结直肠癌患者从2008年至2016年3月8日进行了为期8年的前瞻性随访。我们使用参数治愈模型(混合模型和非混合模型)来估计治愈比例以及术后结直肠癌死亡率的调整风险比(HR)。数据通过R软件(版本3.4.2)中的“flexsurvcure”包进行分析。
患者的中位年龄为57.5岁(四分位间距 = 18岁)。具体而言,56.33%的患者为男性。患者的中位随访时间为618天。累积生存比例从0.90变化至0.49,这表明按性别划分的生存概率先降低而后趋于平稳。调整后的治愈比例(%)的灵活生存率为68.3。仅肥胖与死亡风险降低相关(HR = 0.34;95%置信区间:0.12 - 0.97)。
CRC的总体八年生存比例和调整后的治愈比例分别为49%和68.3%。了解CRC患者的治愈比例及其相关因素,可以提供更好的服务。因此,需要早期检测和筛查策略以降低死亡率并提高患者生存率。